期刊文献+

肝细胞癌术前血清AFP与NLR水平对判断患者预后的应用价值 被引量:1

Value of preoperative serum AFP and NLR levels in predicting prognosis of HCC patients
下载PDF
导出
摘要 目的探讨肝细胞癌(HCC)术前血清甲胎蛋白(AFP)与中性粒细胞与淋巴细胞比值(NLR)水平判断患者预后的价值。方法回顾性分析2014年2月~2016年2月收治的88例于我院行手术治疗的HCC患者的临床资料,依据预后情况分为预后良好组与预后不良组。比较两组性别、年龄、TNM分期、肿瘤直径、是否存在淋巴结转移、是否存在乙型肝炎病毒感染、AFP、NLR差异,通过ROC曲线分析AFP、NLR预测HCC患者预后不良的价值,最后通过多因素logistic回归分析明确HCC预后不良的危险因素。结果两组性别、年龄、是否存在乙型肝炎病毒感染对比无差异(P>0.05);预后不良组TNM分期Ⅲ或Ⅳ期、肿瘤直径≥60 mm、淋巴结转移患者显著多于预后良好组,(P<0.05);预后不良组AFP、NLR显著高于预后良好组,(P<0.05)。经ROC分析AFP、NLR预测HCC患者预后的曲线下面积分别为0.839、0.815,均有P<0.05。经多因素logistic回归分析证实,TNM分期Ⅲ或Ⅳ期、肿瘤直径≥60 mm、淋巴结转移、AFP≥444.26 ng/mL、NLR≥2.65是HCC患者预后不良的危险因素,均有P<0.05。结论HCC的预后影响因素较多,当AFP≥444.26 ng/mL、NLR≥2.65时HCC患者预后较差,临床治疗中应当关注。 Objective To evaluate the predictive value of preoperative serum alpha-fetoprotein(AFP)level and neutrophil-to-lymphocyte ratio(NLR)in the prognosis of patients with hepatocellular carcinoma(HCC).Methods The clinical data of 88 patients with HCC who underwent surgery in our hospital from February 2014 to February 2016 were retrospectively analyzed.According to the prognosis,they were divided into a good prognosis group and a poor prognosis group.The gender,age,the tumor,node,metastasis(TNM)stage,tumor diameter,lymph node metastasis,hepatitis B virus infection,AFP,and NLR between the 2 groups were compared.The value of AFP and NLR in predicting poor prognosis of HCC patients was analyzed by receiver operator characteristic curve.And risk factors for poor prognosis of HCC were identified by multivariate logistic regression analysis.Results There was no difference between the 2 groups in sex,age or the incidence of hepatitis B virus infection(P>0.05).In poor prognosis group,cases of TNM stage III or IV,tumor diameter≥60 mm and lymph node metastasis were significantly more than those in good prognosis group(P<0.05).AFP and NLR in poor prognosis group were significantly higher than those in good prognosis group(P<0.05).The area under the curve of AFP and NLR predicting the poor prognosis of HCC patients was 0.839 and 0.815,respectively(P<0.05).Multivariate logistic regression analysis confirmed that TNM stage III or IV,tumor diameter≥60 mm,lymph node metastasis,AFP≥444.26 ng/mL,NLR≥2.65 were risk factors for poor prognosis of HCC patients(P<0.05).Conclusion The prognosis of HCC is affected by many factors.When AFP≥444.26 ng/mL or NLR≥2.65,the prognosis of HCC patients tends to be poor,which should be paid attention to in clinical treatment.
作者 张海业 彭艺 陆粵就 何丽凤 ZHANG Hai-ye;PENG Yi;LU Yue-jiu;HE Li-feng(Department of Laboratory Medicine,Xinyi People′s Hospital,Guangdong 525300,China)
出处 《肝脏》 2020年第8期825-827,共3页 Chinese Hepatology
关键词 肝细胞性肝癌 甲胎蛋白 中性粒细胞与淋巴细胞比值 Hepatocellular carcinoma Alpha-fetoprotein Neutrophil-to-lymphocyte ratio Prognosis
  • 相关文献

参考文献7

二级参考文献62

  • 1纪全江,孙丽丽.α-L-岩藻糖苷酶检测的临床应用[J].医学检验与临床,2008,20(4):79-80. 被引量:4
  • 2Chen W, Zheng R,Zhang S, et al. Annum report on status of cancer in China,2010[ J]. Chin J Cancer Res,2014 ,26 :48-58.
  • 3Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation [ J ]. Nature ,2008,454:436-44.
  • 4Elinav E, Nowarski R, Thaiss CA, et al. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms [ J ]. Nat Rev Cancer,2013,13:759-771.
  • 5Kao SC, Pavlakis N, Harvie R, et al. High blood neutrophil-to- lymphocyte ratio is an indicator of poor prognosis in malignant mes- othelioma patients undergoing systemic therapy [ J ]. Clin Cancer Res,2010,16:5805-5813.
  • 6Raungkaewmanee S, Tangjitgamol S, Manusirivithaya S, et al. Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer[ J]. J Gynecol Oncol,2013,23:265-273.
  • 7Szkandera J, Gerger A, Liegl-Atzwanger B, et al. The lymphocyte/ monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas [ J ]. Int J Cancer,2014,135:362-370.
  • 8Absenger G, Szkandera J, Pichler M, et al. A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients[ J]. Br J Cancer,2013,109:395-400.
  • 9Teramukai S, Kitano T, Kishida Y, et al. Pretreatment neutrophil count as an independent prognostic factor in advanced non-small- cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03 [ J]. Eur J Cancer,2009,45 : 1950-1958.
  • 10Coussens LM, Werb Z. Inflammation and cancer[ J ]. Nature ,2002, 420 : 860 -867.

共引文献52

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部